Middle ear neuroendocrine tumour-case report of a rare tumour of the temporal bone
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20233589Keywords:
Middle ear neuroendocrine tumour, MeNET, MEA, Carcinoid tumour, Neuroendocrine adenoma of middle ear, NAMEAbstract
Several conditions are known to present as masses in the middle ear medial to an intact tympanic membrane. Reddish masses that blanch on seigelization are usually paragangliomas. Sometimes, a high rising jugular bulb or an aberrant carotid artery can also be seen. Whitish masses are usually congenital cholesteatomas, tympanosclerosis, cartilage grafts that have been surgically placed, and rarely middle ear adenomas (MEA). An elderly male presented with decreased hearing, which was revealed to be secondary to a pale mass in the middle ear, displacing the intact tympanic membrane laterally. He underwent biopsy followed by complete excision of the mass, with preservation of the intact ossicular chain. There no evidence of recurrence on follow-up. Histopathology revealed the mass to be a MEA, also known as middle ear neuroendocrine tumour (MeNET). Middle ear neuroendocrine tumours are rare tumours. We describe the clinical presentation and management of this tumour.
Metrics
References
Baku M, Ueda H. A rare case of middle ear adenoma. Nagoya J Med Sci. 2014;76(3-4):355-60.
Berns S, Pearl G. Middle ear adenoma. Arch Pathol Lab Med. 2006;130(7):1067-9.
Thompson LDR. Tumours of the Ear. In: Fletcher CD. Diagnostic histopathology of tumours. Philadelphia, PA: Elsevier. 2021;52(2):2117-44.
Zan E, Limb CJ, Koehler JF, Yousem DM. Middle ear adenoma: a challenging diagnosis. Am J Neuroradiol. 2009;30(8):1602-3.
Hyams VJ, Michaels L. Benign adenomatous neoplasm (adenoma) of the middle ear. Clin Otolaryngol. 1976;1(1):17-26.
Bierry G, Riehm S, Marcellin L, Stierlé JL, Veillon F. Middle ear adenomatous tumour: a not so rare glomus tympanicum-mimicking lesion. J Neuroradiol. 2010;37(2):116-21.
Sandison A. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear. Head Neck Pathol. 2022;16(1):76-86.
Thompson LD. Neuroendocrine adenoma of the middle ear. Ear Nose Throat J. 2005;84(9):560-1.
Torske KR, Thompson LD. Adenoma versus carcinoid tumour of the middle ear: a study of 48 cases and review of the literature. Mod Pathol. 2002;15:543-55.
Ketabchi S, Massi D, Franchi A, Vannucchi P, Santucci M. Middle ear adenoma is an amphicrine tumour: why call it adenoma? Ultrastructural Pathol. 2001;25(1):73-8.
Ramsey MJ, Nadol JB Jr, Pilch BZ, McKenna MJ. Carcinoid tumour of the middle ear: clinical features, recurrences, and metastases. Laryngoscope. 2005;115(9):1660-66.
Duderstadt M, Förster C, Welkoborsky HJ, Ostertag H. Adenomatous tumours of the middle ear and temporal bone: clinical, morphological and tumour biological characteristics of challenging neoplastic lesions. Eur Arch Oto-Rhino-Laryngol. 2012;269:823-31.
Kvaščevičius L, Lesinskas E, Petroška D, Kvaščevičius R, Šatinskienė I. Late Recurrence of a Rare Middle Ear Neuroendocrine Tumour with an Intracranial Extension to the Temporal Fossa: A Case Report. Cureus. 2023;15(4):e37900.
Atlas M, Ahmed N, O’Sullivan P. Tumours of the Temporal Bone. In: Watkinson JC, Clarke R, editors. Scott-Brown’s Otorhinolarnygology and Head and Neck Surgery. 8th ed. Boca Raton: CRC Press. 2018;1339-47.